Molecular Oncology
Volume 2, Issue 1 , Pages 16-19, June 2008

NESH protein expression switches to the adverse effect of imatinib mesylate

  • Satoru Matsuda

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Environmental Health, Nara Women's University, KitaUoya-Nishimachi, Nara 630-8506, Japan.

Department of Environmental Health, Nara Women's University, KitaUoya-Nishimachi, Nara 630-8506, Japan

Department of Molecular Pathogenesis, Nagoya University School of Medicine, Nagoya 466-8550, Japan

Department of Molecular Pathogenesis, Nagoya University School of Medicine, Nagoya 466-8550, Japan

1INSERM, U841, Créteil, France

Department of Environmental Health, Nara Women's University, KitaUoya-Nishimachi, Nara 630-8506, Japan

Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan

published online 17 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1574-7891(08)00036-7

doi:10.1016/j.molonc.2008.03.003

Molecular Oncology
Volume 2, Issue 1 , Pages 16-19, June 2008